Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency Transcript

Corroborated by 1 source from 1 publisher

globalgeneral4h ago

TL;DR

According to seekingalpha.com, beam Therapeutics Inc.

Sources

1

Seeking Alpha Market News

https://seekingalpha.com/article/4885919-beam-therapeutics-inc-beam-discusses-topline-phase-i-ii-data-for-beamminus-302-in-alphaminus?source=feed_all_articles

4h ago